JPH0678366B2 - Manufacturing method of chrysanthemum polysaccharides - Google Patents
Manufacturing method of chrysanthemum polysaccharidesInfo
- Publication number
- JPH0678366B2 JPH0678366B2 JP62061894A JP6189487A JPH0678366B2 JP H0678366 B2 JPH0678366 B2 JP H0678366B2 JP 62061894 A JP62061894 A JP 62061894A JP 6189487 A JP6189487 A JP 6189487A JP H0678366 B2 JPH0678366 B2 JP H0678366B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- ultrafiltration
- molecular weight
- fungus
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
本発明は、インターフェロンの産生能を高め、ナチュラ
ルキラー活性を強めるなどの人免疫系を活性化する作用
を有するキクラゲ多糖体の製法に関する。TECHNICAL FIELD The present invention relates to a method for producing a chrysalis polysaccharide having an action of activating the human immune system such as enhancing interferon producing ability and enhancing natural killer activity.
インターフェロンは、細胞が作る天然物で細胞に作用す
る一種のホルモン様物質であり、発見されて以来、ウィ
ルス、免疫低下、一部の癌などに有効な物質とされなが
らも、その投与方法に関して経口投与によっては吸収さ
れないので未だに議論をよんでいる。 インターフェロンに関する研究は多く行われており、NH
細胞(ナチュラルキラー;自然癌破壊作用)を介する作
用、細胞の分化がインターフェロンにより促進または誘
導されることによるという制癌作用や、NH−IFNシステ
ムの動物や人のウィルス病や、種痘の発病と伸展、転移
と予後にいかに重要な関係を持つかなどの研究が進めら
れ発表されている。 いずれにしても、インターフェロンが欠如したりかなり
低下すれば、マクロファージやNH細胞を介さなくともウ
ィルス病には感染し易く重傷になりやすいと考えられる
し、NHやインターロイキンその他のリンホカインとの協
同、更には、マクロファージ、多核白血球や免疫担当細
胞との関係に不全を来して発癌し易くなるもとの推定さ
れている。Interferon is a natural product produced by cells and a kind of hormone-like substance that acts on cells.Since its discovery, it has been regarded as an effective substance for viruses, immunosuppression, some cancers, etc. It is still controversial because it is not absorbed by administration. There are many studies on interferon, NH
Actions mediated by cells (natural killer; natural cancer destroying action), anti-cancer action due to cell differentiation being promoted or induced by interferon, viral disease of NH-IFN system in animals and humans, and onset of smallpox Studies on how important the relationship between extension, metastasis, and prognosis have been promoted and announced. In any case, if interferon is deficient or significantly lowered, it is considered that it is easy to be infected with a viral disease even if it does not involve macrophages and NH cells, and it is likely to cause serious injury, and cooperation with NH, interleukin and other lymphokines, Furthermore, it is presumed that the relationship between macrophages, polynuclear leukocytes, and immunocompetent cells may be impaired, resulting in easy carcinogenesis.
インターフェロンの投与による問題解決を側面よりみて
インターフェロンの欠如や低下を防ぐため、逆に、イン
ターフェロンを体内にて増加させれば前記の如き感染性
ウィルスの生産を抑制し発病を防ぐことができるとの見
地より、優れたインターフェロン産生能の高い物質や、
NH活性の活性化物質の開発が待たれている。In order to prevent the lack or reduction of interferon from the aspect of problem solving by administering interferon, conversely, increasing interferon in the body can suppress the production of infectious virus as described above and prevent the onset of disease. From a viewpoint, substances with excellent interferon-producing ability,
The development of NH active activators is awaited.
本発明者らは、インターフェロン産生能を高め、且つNH
活性をも高める物質の検索を行い、多くの物質の中より
キクラゲ多糖体がこの目的のために優れた効力を発揮す
ることを見いだし、その製造法を確立してここに本発明
を完成した。 すなわち、キクラゲを熱水で抽出し、該抽出液を限外濾
過し、得られた限外濾過内液に低級アルコールを加え、
生成する沈澱を採取することを特徴とするキクラゲ多糖
体の製法である。 キクラゲはキクラゲ科の植物、木耳(モクジ)Auricula
ria auricula(L.ex Hook)Underw の子実体で中国の四
川省、福建省、江蘇省にて産出されている。 このものは薬効があるといわれており、中葯大辞典によ
ると、その薬効は主として出血抑制作用にあり中国薬膳
の一素材として用いられている。 日本においても年間約400トンが輸入され利用されてい
る。 本発明になるキクラゲ多糖体は、キクラゲの熱水による
抽出物を特定の方法で精製することにより製せられる。 その製法の概要について以下に述べる。 まず、乾燥キクラゲをよく冷水にて洗い、次いで熱水に
てその可溶性区分を抽出し、固形分を除去した後に遠心
分離によって清澄はキクラゲエキスを得る。 得られた清澄液は濃縮することなく、そのまま限外濾過
に付される。 限外濾過は、分画分子量、約10,000乃至200,000の限外
濾過膜を用い、常法にしたがって加圧下に実施される。 濾過膜は、上記分画分子量を有するものであればよく、
材質など特に制限はない。 ここに用いる濾過膜の例としては、東洋濾紙株式会社製
品のUK−10(分画分子量、10,000)、UP−20(分画分子
量、20,000)、UK−50(分画分子量、50,000)、UK−20
0(分画分子量、200,000)、日東電工株式会社製品のNT
U−2000シリーズ(分画分子量、20,000〜100,000)、NT
U3000シリーズ(分画分子量、8,000〜100,000)、NTU−
4000シリーズ(分画分子量、6,000〜200,000)等があげ
られる。 特に上記のうち、UK−200,NTU−2000シリーズが好まし
い。 ここで濾過に際しての加圧は、0.5〜2.0kg/cm2が適当で
ある。 限外濾過により得られた液体に、メタノール、エタノー
ル、イソプロピルアルコールなどの低級アルコールを加
えることにより沈澱を生じさせこれを濾別する。 この沈澱精製物は、常法により乾燥して製品とするが、
品質の面から見て凍結乾燥法によるのが好ましい。 得られたキクラグ多糖体の凍結乾燥品は、黄褐色の粉末
であって、水に可溶であり、メタノール、エタノール、
アセトン、エーテル、クロロホルム、酢酸エチル、ベン
ゼン及びヘキサンなどの有機溶剤に不溶である。 呈色反応は、フェノール硫酸反応、アンスロン硫酸反応
に陽性である。 紫外線吸収スペクトルは、水溶液中の測定で吸収極大値
を示さず、末端吸収のみを示す。これを第1図に示し
た。 また赤外線吸収スペクトルを第2図に示した。The present inventors have increased interferon production ability and
By conducting a search for substances that also enhance the activity, it was found that among many substances, the salmonella jellyfish exhibits excellent potency for this purpose, the manufacturing method thereof was established, and the present invention was completed here. That is, the fungus is extracted with hot water, the extract is ultrafiltered, and a lower alcohol is added to the obtained ultrafiltration inner solution,
This is a method for producing a fungus, a jellyfish polysaccharide, which is characterized in that the formed precipitate is collected. Asteraceae is a plant of the family Asteraceae, Auricula
The fruiting body of ria auricula (L.ex Hook) Underw is produced in Sichuan, Fujian and Jiangsu provinces of China. It is said that this drug has medicinal properties, and according to the Chu Andai Dictionary, the medicinal properties are mainly due to bleeding suppressive action and are used as a material of Chinese medicinal herbs. In Japan, about 400 tons are imported and used annually. The Pleurotus cornucopiae polysaccharide according to the present invention can be produced by purifying an extract of Pleurotus cornucopiae with hot water by a specific method. The outline of the manufacturing method is described below. First, the dried fungus is thoroughly washed with cold water, then the soluble fraction is extracted with hot water, the solid content is removed, and then clarified by centrifugation to obtain a fungus extract. The obtained clear liquid is subjected to ultrafiltration as it is without being concentrated. Ultrafiltration is carried out under pressure according to a conventional method using an ultrafiltration membrane having a molecular weight cut off of about 10,000 to 200,000. The filtration membrane may be one having the above-mentioned molecular weight cut-off,
There is no particular limitation on the material. Examples of filtration membranes used here include Toyo Roshi Kaisha Ltd. products UK-10 (fraction molecular weight, 10,000), UP-20 (fraction molecular weight, 20,000), UK-50 (fraction molecular weight, 50,000), UK -20
0 (molecular weight cutoff, 200,000), NT of Nitto Denko Corporation product
U-2000 series (molecular weight cutoff, 20,000 to 100,000), NT
U3000 series (molecular weight cutoff, 8,000 to 100,000), NTU-
The 4000 series (molecular weight cutoff, 6,000 to 200,000) are listed. Of these, the UK-200 and NTU-2000 series are particularly preferable. Here, the pressure applied during filtration is suitably 0.5 to 2.0 kg / cm 2 . A lower alcohol such as methanol, ethanol or isopropyl alcohol is added to the liquid obtained by ultrafiltration to cause precipitation, which is filtered off. The purified product precipitated is dried by a conventional method to give a product.
From the viewpoint of quality, the freeze-drying method is preferable. The lyophilized product of the obtained Kikulag polysaccharide is a yellowish brown powder, which is soluble in water, and contains methanol, ethanol,
It is insoluble in organic solvents such as acetone, ether, chloroform, ethyl acetate, benzene and hexane. The color reaction is positive for phenol-sulfuric acid reaction and anthrone-sulfuric acid reaction. The ultraviolet absorption spectrum shows no maximum absorption value when measured in an aqueous solution, and shows only terminal absorption. This is shown in FIG. The infrared absorption spectrum is shown in FIG.
以下に実施例及び応用例を以て、本発明を詳細に説明す
るが、本発明はこの実施例に限定されないこと勿論であ
る。 〔実施例−1〕 キクラゲ50gを冷水にてよく洗った後に、水3000gを加
え、100℃にて1時間抽出を行い、カーゼを用いて固形
物を除き抽出液1000gを得た。 上記固形分に再び水1000gを加え、100℃にて1時間抽出
を行い、カーゼを用いて固形分を除き1000gの抽出液を
得た。 該抽出液を最初に得られた抽出液と合わせた後に、この
2000g(Bx0.2)の抽出液に濾過助剤として10gのセライ
ト545を加えて濾過を行い、透明な濾液を得た。 この濾過を限外濾過器UHP−90(東洋濾紙株式会社
製)、濾過膜UK−200(分画分子量200,000;(東洋濾紙
株式会社製)を用いて、室温、2.0kg/cm2の圧力下で限
外濾過を行った。 濾過液400gを得たところで、残濾液に水400gを加え限外
濾過を続ける。 更に、同様の操作を2回繰り返し、残濾液として、多糖
体区分約200g(Bx2.0)を得、これにエタノール800mlを
加え、生じた沈澱を濾別した。 この沈澱精製物を凍結乾燥して3.6gのキクラゲ多糖体を
得た。 〔実施例−2〕 キクラゲ15kgに水900kgを加え、100℃にて1時間抽出を
行い、次にパルパーフィニッシャーにかけて固形分を除
き約300kgの抽出液を得た。 上記固形分に再び水300kgを加え、100℃にて1時間抽出
を行い、〔実施例−1〕と同様に後処理をおこない約30
0kgの抽出液を得た。 該抽出液を最初に得られた抽出液と合わせてこの約600k
gの抽出液を遠心分離した後、濾過助剤として2.0kgのセ
ライト545を加え、攪拌後スパクラフィルターを用いて
濾過を行い透明な濾液560kg(Bx0.2)を得た。 この濾液を限外濾過器RW−1型(日東電工株式会社
製)、濾過膜NTU−2000−P・18−B(分画分子量100,0
00;日東電工株式会社製)を用いて限外濾過を行った。 濾液420kgを得たところで、水140kgを加え限外濾過をつ
づけ、更に同様の操作を2回繰り返し、残渣として多糖
体区分約140kgを得た。 このものを減圧下に濃縮し、約60kg(Bx2.0)とし、こ
れにエタノール240kgを加え、生じた沈澱を濾別し、続
いて凍結乾燥を行いキクラゲ多糖体1.0kgを得た(以下
本品という)。 〔応用例−1〕 男女各5名(年齢20代〜50代)に本品1日2.1gを毎昼食
30分前に14日間連続投与した。 投与を開始したその翌日(投与開始2日目)、8日目、
15日目、22日目にα型インターフェロン(IFN−α)産
生能に対する効果を測定した。 測定方法は、125I・IFN−αを用いた競合法でおこなっ
た。 IFN−αの産生能は、本品を投与する前と比較して、投
与後では著しく産生能が高まることが明らかになり、本
品のインターフェロン産生能に対する有効生が証明され
た。 この測定結果を〔表−1〕に示す。 〔応用例−2〕 男女各5名(年齢20代〜50代)に、本品1日2.1gを、毎
昼食30分前に14日間連続投与した。 投与を開始したその翌日(投与開始2日目)、8日目、
15日目、22日目にナチュラルキラー活性(NH活性)を測
定した。 測定方法は、ターゲット細胞として、51Crでラベルした
HeLa細胞を用いたCytotoxic assayを用いた。 NH活性は、本品の投与によって、明らかな上昇を示し、
本品のNH活性の活性化に対する有効性が証明された。 この測定結果を〔表−2〕に示す。 The present invention will be described in detail below with reference to examples and application examples, but it goes without saying that the present invention is not limited to these examples. [Example-1] After thoroughly washing 50 g of the fungus Jellyfish with cold water, 3000 g of water was added, extraction was carried out at 100 ° C for 1 hour, and solid matter was removed using a case to obtain 1000 g of an extract. 1000 g of water was added to the above solid content again, extraction was carried out at 100 ° C. for 1 hour, and the solid content was removed using a case to obtain 1000 g of an extract. After combining the extract with the extract obtained first,
To 2000 g (Bx0.2) of the extract, 10 g of Celite 545 as a filter aid was added and filtered to obtain a transparent filtrate. This filtration was performed at room temperature under a pressure of 2.0 kg / cm 2 using an ultrafilter UHP-90 (manufactured by Toyo Roshi Kaisha, Ltd.) and a filtration membrane UK-200 (molecular weight cutoff of 200,000; manufactured by Toyo Roshi Kaisha, Ltd.). When 400 g of filtrate was obtained, 400 g of water was added to the residual filtrate, and ultrafiltration was continued, and the same operation was repeated twice to obtain a residual filtrate of about 200 g (Bx2 .0), 800 ml of ethanol was added thereto, and the resulting precipitate was separated by filtration.The purified product of the precipitate was lyophilized to obtain 3.6 g of a jellyfish polysaccharide. 900 kg was added and extraction was carried out for 1 hour at 100 ° C. Then, the solid content was removed by applying a pulper finisher to obtain about 300 kg of extract liquid. Then, post-treatment is carried out in the same manner as in [Example-1] to obtain about 30
0 kg of extract was obtained. This extract is combined with the extract obtained first to give about 600 k
After centrifuging the extract of g, 2.0 kg of Celite 545 was added as a filter aid, and the mixture was stirred and filtered using a spakura filter to obtain 560 kg of a transparent filtrate (Bx0.2). This filtrate was used as an ultrafilter RW-1 type (manufactured by Nitto Denko Corporation), a filtration membrane NTU-2000-P.18-B (fraction molecular weight 100,0).
00; manufactured by Nitto Denko Co., Ltd.). When 420 kg of the filtrate was obtained, 140 kg of water was added and ultrafiltration was continued, and the same operation was repeated twice to obtain about 140 kg of a polysaccharide fraction as a residue. This product was concentrated under reduced pressure to about 60 kg (Bx2.0), and 240 kg of ethanol was added to this, and the resulting precipitate was filtered off, followed by freeze-drying to obtain 1.0 kg of the jellyfish polysaccharide (hereinafter referred to as " Goods). [Application example-1] 2.1g of this product per day will be served to 5 men and women (ages 20s to 50s) every day
It was administered 30 minutes before for 14 consecutive days. The day after the start of administration (the second day of administration), the eighth day,
On the 15th and 22nd days, the effect on the α-type interferon (IFN-α) -producing ability was measured. The measurement method was a competitive method using 125 I · IFN-α. The IFN-α production ability was revealed to be significantly higher after administration than before administration of this product, demonstrating that this product is effective against interferon production ability. The measurement results are shown in [Table-1]. [Application Example-2] 2.1 g of this product was administered to 5 males and 5 females (aged 20s to 50s) daily for 14 days 30 minutes before lunch. The day after the start of administration (the second day of administration), the eighth day,
The natural killer activity (NH activity) was measured on the 15th and 22nd days. The measurement method was labeled with 51 Cr as target cells.
Cytotoxic assay using HeLa cells was used. NH activity shows a clear increase by administration of this product,
The effectiveness of this product for activation of NH activity was proved. The measurement results are shown in [Table-2].
本発明になるキクラゲ多糖体は、IFNの産生能、NH活性
などの人免疫系を活性化することにより、癌、風邪、肝
炎などの予防、治療の効果を期待できる疾患に対する医
薬品、食品、栄養補助食品などに使用、応用することが
できる。The jellyfish polysaccharide according to the present invention is a drug, food, or nutrition for diseases that can be expected to have preventive or therapeutic effects on cancer, colds, hepatitis, etc. by activating the human immune system such as IFN production ability and NH activity. It can be used and applied to supplement foods.
第1図は本発明のキクラゲ多糖体の紫外線吸収スペクト
ルを示す図、第2図は同赤外線吸収スペクトルを示す図
である。FIG. 1 is a diagram showing an ultraviolet absorption spectrum of the jellyfish polysaccharide of the present invention, and FIG. 2 is a diagram showing the infrared absorption spectrum of the same.
Claims (2)
濾過し、得られた限外濾過内液に低級アルコールを加
え、生成する沈澱を採取してなることを特徴とするキク
ラゲ多糖体の製法。1. A fungus fungus, characterized in that the fungus is extracted with hot water, the extract is subjected to ultrafiltration, a lower alcohol is added to the obtained ultrafiltration inner solution, and the resulting precipitate is collected. Polysaccharide manufacturing method.
000であることを特徴とする特許請求の範囲第1項に記
載のキクラゲ多糖体の製法。2. An ultrafiltration membrane having a molecular weight cutoff of 10,000 to 200,
The method for producing the chrysalis polysaccharides according to claim 1, which is 000.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62061894A JPH0678366B2 (en) | 1987-03-17 | 1987-03-17 | Manufacturing method of chrysanthemum polysaccharides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62061894A JPH0678366B2 (en) | 1987-03-17 | 1987-03-17 | Manufacturing method of chrysanthemum polysaccharides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63226293A JPS63226293A (en) | 1988-09-20 |
| JPH0678366B2 true JPH0678366B2 (en) | 1994-10-05 |
Family
ID=13184305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62061894A Expired - Lifetime JPH0678366B2 (en) | 1987-03-17 | 1987-03-17 | Manufacturing method of chrysanthemum polysaccharides |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0678366B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100780664B1 (en) | 2007-01-26 | 2007-11-30 | 대구대학교 산학협력단 | Polysaccharide derived from the fruiting body of the oleander mushroom having hypolipidemic effect and a method of producing the same |
| KR101013866B1 (en) | 2008-08-07 | 2011-02-14 | 경원대학교 산학협력단 | Method for extracting anti-thrombotic food from thirsty mushrooms and antithrombotic extract |
| CN110467684A (en) * | 2018-05-11 | 2019-11-19 | 东北林业大学 | A kind of method of cation macroreticular resin purification Blackfungus polyhexose |
| CN114409820B (en) * | 2022-01-27 | 2022-10-28 | 吉林农业大学 | Preparation method of Auricularia fuscosuccinea iron-containing mannan, and product and application thereof |
-
1987
- 1987-03-17 JP JP62061894A patent/JPH0678366B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63226293A (en) | 1988-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0657721B2 (en) | Polysaccharides, especially extracted from plants, useful as pharmaceutical and food additives | |
| JPS6219525A (en) | Production of plant-originated bioactive substance and composition containing said substance | |
| JPH0678366B2 (en) | Manufacturing method of chrysanthemum polysaccharides | |
| CA2035948A1 (en) | Polysaccharides with immunomodulating properties from astragalus membranaceus and pharmaceutical compositions containing them | |
| DK145424B (en) | PROCEDURE FOR MANUFACTURING NITROGEN CONTAINING POLYSACCHARIDES WITH ANTI-TUMOR-EFFECTIVE | |
| KR870001930B1 (en) | Manufacturing method of polysaccharide RON material | |
| EP0395757B1 (en) | Process for extracting physiologically active substance from pine seed shells and antiinfectant prepared mainly from the extract | |
| JP4233029B2 (en) | Maitake extract, glycoprotein, and production method thereof | |
| JP2784605B2 (en) | Lignin glycosides and uses thereof | |
| JPH07116241B2 (en) | Method for producing bioactive polysaccharide RON derived from rice bran | |
| JP3051073B2 (en) | Antitumor active substance | |
| JPH11228602A (en) | Immunity enhancer and immunity enhancer food | |
| JPH072649B2 (en) | Process for producing pruned polysaccharide | |
| CN101152557A (en) | Preparation of water extract and zymolyte of ground beetle dry powder and application in medicine | |
| US4440761A (en) | Interferon inducer, a process for producing the same and pharmaceutical composition containing the same | |
| JP3254567B2 (en) | Method for producing physiologically active substance from plant tissue and composition containing this substance | |
| JPS6045603B2 (en) | Method for extracting substances with antihypertensive effect | |
| JPS6152807B2 (en) | ||
| JPH0351689B2 (en) | ||
| JP4197996B2 (en) | Interferon production promoter | |
| JPH05306233A (en) | Hot water extract of lyophyllum ulmarium | |
| JP2875397B2 (en) | Anti-infective agent and method for producing the same | |
| US3584123A (en) | Method of treatment of skin diseases and therapeutic products from the roots of securidaca longipedonculata | |
| JP3290957B2 (en) | Composition containing aqueous extract of Moroheiya | |
| US943578A (en) | Digitalis extract. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |